Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

857 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.
Iwamoto H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Kano H, Makino T, Naito R, Kadomoto S, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A. Iwamoto H, et al. Among authors: kano h. Biomedicines. 2022 Sep 22;10(10):2369. doi: 10.3390/biomedicines10102369. Biomedicines. 2022. PMID: 36289628 Free PMC article.
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
Kano H, Izumi K, Hiratsuka K, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Shimada T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Saito Y, Nakagawa-Goto K, Yoshioka K, Nakata H, Lin WJ, Mizokami A. Kano H, et al. Cancer Sci. 2023 Apr;114(4):1479-1490. doi: 10.1111/cas.15683. Epub 2022 Dec 18. Cancer Sci. 2023. PMID: 36479732 Free PMC article.
Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells.
Shimada T, Naito R, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Kano H, Kadomoto S, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Nakata H, Saito Y, Nakagawa-Goto K, Mizokami A. Shimada T, et al. Among authors: kano h. Anticancer Res. 2023 Jun;43(6):2433-2444. doi: 10.21873/anticanres.16411. Anticancer Res. 2023. PMID: 37247901
Role of Positive Biopsy Core Ratio in Prostate Cancer Patients.
Kano H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A. Kano H, et al. Anticancer Res. 2023 Oct;43(10):4619-4626. doi: 10.21873/anticanres.16656. Anticancer Res. 2023. PMID: 37772589
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer.
Kano H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Makino T, Naito R, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Nohara T, Mizokami A. Kano H, et al. Biomedicines. 2024 Jan 26;12(2):292. doi: 10.3390/biomedicines12020292. Biomedicines. 2024. PMID: 38397894 Free PMC article.
Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
Nakagawa R, Nohara T, Kano H, Makino T, Naito R, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Izumi K, Mizokami A. Nakagawa R, et al. Among authors: kano h. Photodiagnosis Photodyn Ther. 2024 Feb 22;46:104023. doi: 10.1016/j.pdpdt.2024.104023. Online ahead of print. Photodiagnosis Photodyn Ther. 2024. PMID: 38401816 Free article.
Comprehensive analysis of perioperative hypotension in photodynamic diagnosis-assisted transurethral resection of bladder tumor with 5-aminolevulinic acid.
Nohara T, Takimoto A, Shinzawa R, Kurauchi D, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Kano H, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Izumi K, Mizokami A. Nohara T, et al. Among authors: kano h. Int J Urol. 2024 Apr 30. doi: 10.1111/iju.15477. Online ahead of print. Int J Urol. 2024. PMID: 38687138
857 results